Epidemiological Study of Malignant Paediatric Liver Tumours in Denmark 1985-2020.
Thomas Nørrelykke NissenCatherine RechnitzerBirgitte Klug AlbertsenLotte BorgwardtVibeke B ChristensenEva FallentinHenrik HasleLars S JohansenLisa L MarounKarin B NissenAllan RasmussenMathias RatheSteen RosthøjNicolai A SchultzPeder S WehnerMarianne H JørgensenJesper BrokPublished in: Cancers (2023)
In Denmark, incidences of malignant liver tumours during the last four decades have been increasing, as reported in the literature. HB survival has improved since the year 2000 and is comparable with international results. Reduced hearing is the major treatment-related side effect and affects approximately 60% of patients.